$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / HSA and FSA for tirzepatide
Pre-tax dollars. One flat price.
Yes, when a physician prescribes it to treat a diagnosed disease, such as obesity: the IRS counts prescribed medicines as medical expenses, but not weight loss for appearance. At NexLife, HSA and FSA cards work at checkout, and a year of tirzepatide costs $1,668 to $2,028.
Not sure what your plan needs? Call or text (949) 818-8000. We’ll tell you what we can send before you pay.
4.8 out of 5 on Trustpilot · LegitScript certified
The rule
One rule decides almost everything: is the treatment for a disease a physician has diagnosed?
| Expense | Counts? | What the IRS says |
|---|---|---|
| Prescribed medicine | Can count | Medicines and drugs a physician prescribes count. Medical care has to be mainly for an illness, not general health. |
| Weight-loss treatment for a diagnosed disease | Can count | Counts when the weight loss treats a specific disease a physician diagnosed, such as obesity, hypertension or heart disease. |
| Nutrition counseling | Sometimes | Counts only when it treats a specific disease a physician diagnosed, such as obesity. |
| Weight loss for appearance or general health | Doesn’t count | The IRS excludes weight loss to improve appearance, general health or a sense of well-being. |
| Diet food and drinks | Doesn’t count | They replace what you’d normally eat, so they don’t count. |
From IRS Publication 502 and the IRS’s questions and answers on nutrition, wellness and general health. HSA and FSA plans follow these rules; an FSA can cover fewer expenses than the IRS allows.
Do the math
HSA and FSA money goes in before income tax. On a year of tirzepatide, that’s real money saved.
| Tax bracket | Saved on $2,028 (month to month) | Saved on $1,668 (12-month plan) |
|---|---|---|
| 12% | $243 | $200 |
| 22% | $446 | $367 |
| 24% | $487 | $400 |
| 32% | $649 | $534 |
Federal income tax only, rounded to the dollar. If your HSA or FSA contributions come out of your paycheck, you usually also skip the 7.65% Social Security and Medicare tax on them. State rules vary. This is general information, not tax advice. Your plan administrator or a tax professional can confirm how your plan works.
A year of self-pay Zepbound at LillyDirect’s prices is about $5,188. That’s more than the whole $3,400 FSA limit for 2026. A year at NexLife fits inside it, with room to spare.
Your HSA or FSA can make care easier to budget. The rules matter, so here they are, in plain words.
Real people, real numbers. Call or text (949) 818-8000 and ask what your plan may need.
Check my eligibility, $169/mo
Side by side
The same IRS rule, checked two different ways.
| HSA | FSA | |
|---|---|---|
| How you pay | Your HSA card, or pay another way and reimburse yourself later | Your FSA card, or pay and send your plan a claim |
| Who checks the expense | You do. Keep records that show each withdrawal paid a qualified medical expense | Your plan does, with a receipt or other third-party statement |
| If it doesn’t qualify | The withdrawal is taxed, and usually faces an extra 20% tax | Your plan won’t reimburse it |
| Leftover money | Stays yours, year after year | Use it by the plan’s deadline; some plans offer a grace period or carry over up to $680 |
| 2026 limit | $4,400 self-only or $8,750 family, with an HSA-compatible health plan | $3,400 from your pay |
From IRS Publication 969, Rev. Proc. 2025-19 and the IRS’s 2026 inflation adjustments.
What changed
Since January 1, 2026, bronze and catastrophic health plans count as HSA-compatible, even when they don’t meet the usual high-deductible rules (IRS Notice 2026-5). If you’re on one, you may be able to open an HSA and pay for treatment with pre-tax dollars.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
$169/mo
Weekly and dual-action. Care, coaching and shipping included.
Get started$139/mo
Weekly GLP-1. Care, coaching and shipping included.
Get startedPrescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose. Prices checked October 7–8, 2026.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider and we’ll match your regular monthly price. See the terms
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider, checked October 7–8, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Already on compounded tirzepatide or semaglutide? Bring your price to NexLife. If you pay less with another licensed U.S. telehealth provider, we match your regular monthly price for as long as your plan stays active.† You keep your price, and you gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and real people who answer 24/7.
Locked while your plan is activeSame price at every doseNo membership fee
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price on the month-to-month plan, for the same medication (medication plus required fees; not first-month offers, coupons or prepaid multi-month rates), for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
At NexLife
With an FSA, ask whether it covers prescribed weight-loss medication and what proof it wants. With an HSA, the IRS rules above apply.
About 3 minutes online. A licensed provider decides whether treatment is right for you.
At checkout, like any card. If a card doesn’t go through, pay another way and claim it afterward.
Save each receipt and your prescription details, for a claim, a card review or your tax records.
Tell us what your plan asks for. Call or text us 24/7 at (949) 818-8000, and we’ll tell you what we can send, such as an itemized receipt, before you pay. Some FSAs also ask for a letter of medical necessity; ask us whether your NexLife provider can write one.
It can be. HSA money can pay for compounded tirzepatide when a physician prescribes it to treat a disease they’ve diagnosed, such as obesity. For appearance or general health, it doesn’t qualify.
The same IRS rule applies, and your FSA plan decides how it checks claims. Many ask for a receipt, and some ask for a letter of medical necessity.
It depends on the diagnosis. The IRS counts weight-loss treatment for a specific disease a physician diagnosed; its examples are obesity, hypertension and heart disease.
Yes, under the same rules. A year of self-pay Zepbound at LillyDirect’s prices is about $5,188, more than the 2026 FSA limit of $3,400 and the $4,400 self-only HSA limit.
With an HSA, yes, for expenses after you opened the account, as long as you keep the records. With an FSA, file within your plan’s claim deadline.
The withdrawal counts as income, and it usually faces an extra 20% tax unless you’re 65 or older or disabled.
Yes. NexLife accepts HSA and FSA cards at checkout for compounded tirzepatide ($169 a month at every dose) and semaglutide ($139).
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety informationIn studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Leads the NexLife clinical team, which medically reviewed this page on October 8, 2026.
the IRS’s rules for medical expenses (Publication 502 and its nutrition and wellness questions), HSA and FSA rules (Publication 969), the 2026 limits, Notice 2026-5 and NexLife’s payment options
Start online in about 3 minutes. Pay with your HSA or FSA card, $169 a month at every dose.
A short online health assessment, about 3 minutes.
You’re prescribed only if treatment is right for you.
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, 24/7 support.